New injection aims to melt dangerous neck plaques in High-Fat patients

NCT ID NCT07050134

ENROLLING_BY_INVITATION Disease control Sponsor: Junbo Ge Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an injected drug called DR10624 in 40 adults with high triglycerides and fatty buildup in their neck arteries. Participants receive either the drug or a placebo for 24 weeks, with doses gradually increased. The main goal is to see if the drug reduces artery wall thickness and plaque size, which could lower heart attack and stroke risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertriglyceridemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Suzhou Municipal Hospital

    Suzhou, Jiangsu, 215001, China

  • The Central Hospital of Xuhui District

    Shanghai, Shanghai Municipality, 200020, China

  • The First Affiliated Hospital of Anhui Medicaluniversity

    Hefei, Anhui, 230022, China

  • Zhongshan Hospital Affiliated with Fudan University

    Shanghai, Shanghai Municipality, China